Ixico Plc

  • Market Cap: Micro Cap
  • Industry: Miscellaneous
  • ISIN: GB00BFXR4C20
GBP
0.11
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Ixico Plc stock-summary
stock-summary
Ixico Plc
Miscellaneous
IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa, mehealth, MyBrainBook and TrialTracker. Assessa is a decision-support tool for healthcare professionals looking to diagnose dementia and detect the underlying causes. mehealth is an online software for clinicians at the point-of-care to support decision making and improve the monitoring and treatment of patients. MyBrainBook is a digital platform to improve the quality of life and service delivery for people living with dementia and their supporters. TrialTracker is a Web-based system that allows users to track their imaging-based research study or clinical trial in real time. It is also collaborating with partners to develop companion digital health products.
Company Coordinates stock-summary
Company Details
4th Fl, Griffin Court, 15 Long Lane , LONDON None : EC1A 9PN
stock-summary
Tel: 44 20 37637499
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Charles Spicer
Non-Executive Chairman of the Board
Giulio Cerroni
Chief Executive Officer, Director
Mr. Grant Nash
Chief Financial Officer, Executive Director
Mr. Derek Hill
Executive Director
Ms. Maina Bhaman
Non-Executive Director
Mr. John Bradshaw
Non-Executive Director
Mr. Mark Warne
Non-Executive Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

GBP 10 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.39

stock-summary
Return on Equity

-12.58%

stock-summary
Price to Book

0.81